Fundraising Fox
Manifold
Boston, US · Founded 2019 · 76 employees on LinkedIn · 6 known investors
Find your way into Manifold
Each arrow is one introduction. Sign up to fill in the first one.
Ask Steve Holtzman to introduce you to Pierce Ogden
You →Steve · together at Manifold →Pierce
Sign up to find every way you can get introduced to Manifold
- Your email: who you already know at Manifold, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Manifold team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Manifold Bio combines AI-guided protein design with high-throughput in vivo screening to engineer tissue-targeted biologics and deliver therapeutic payloads to specific organs. The company develops a computational and experimental platform to optimize pharmacokinetics and biodistribution directly in living systems for drug discovery and development.
Founders & leadership
Manifold was founded in 2019 by Gleb Kuznetsov and Pierce Ogden.
Board
Investors · 6
How we know: Playground Global's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Fifty Years's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$78.2M disclosed across 3 rounds · 2020–2024
▶$32.8MraisedDec 2024 · 10 investors · BiotechnologyRule 506(b)
- Jory BellDirector
- Gleb KuznetsovExecutive Officer, Director
- Jeff HuberDirector
- Pierce OgdenExecutive Officer, Director
- Steven J. KafkaDirector
- Steven HoltzmanDirector
- Offering amount
- $32.8M
- Amount sold
- $32.8M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40MraisedJun 2022 · 13 investors · BiotechnologyRule 506(b)
- Jeff HuberDirector
- Pierce OgdenExecutive Officer, Director, Promoter
- Gleb KuznetsovExecutive Officer, Director, Promoter
- Jory BellDirector
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$5.4MraisedAug 2020 · 6 investors · BiotechnologyRule 506(b)
- Pierce OgdenExecutive Officer, Director, Promoter
- Gleb KuznetsovExecutive Officer, Director, Promoter
- Jory BellDirector
- Offering amount
- $5.4M
- Amount sold
- $5.4M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as Manifold.
In the news
Frequently asked questions
- What does Manifold do?
- Manifold Bio combines AI-guided protein design with high-throughput in vivo screening to engineer tissue-targeted biologics and deliver therapeutic payloads to specific organs. The company develops a computational and experimental platform to optimize pharmacokinetics and biodistribution directly in living systems for drug discovery and development.
- Who founded Manifold?
- Manifold was founded by Gleb Kuznetsov, Pierce Ogden in 2019.
- Who are Manifold's investors?
- Manifold's investors include Playground Global, Fifty Years, FPV, Horizons Ventures, Triatomic Capital, Third Rock Ventures.
- How much funding has Manifold raised?
- Manifold has disclosed $78.2M raised across 3 rounds.
- Where is Manifold headquartered?
- Manifold is headquartered in Boston, US.